Here is the news, when an investigation goes on a clinical study, it is because there are quite a few indications that something may be, since unfortunately every study needs economic resources, time and work.
The investigation is being carried out in the US and Italy simultaneously, I say that it will be for something, but we go that if you already know the answer we call them to focus on other paths and thus we are optimized by resources.
The study is called Poseidon Study
Study of the University of Miami analyzes whether Omega 3 and vitamin D can stop the progress of type 1 diabetes
By Julie Landry Laviolette Special/Miami Heral
I leave you the news in case you don't find it.By the way, see how it is the one that develops the insulin and will be the ones that sooner or later on the key.
Pediatric and adult patients of type 1 diabetes are sought for a clinical study with the aim of testing if high doses of omega 3 and vitamin D can stop the progress of the disease.
The Diabetes Research Institute of the Miller Medicine School at the University of Miami conducts the study.
The Poseidon study will examine the safety and effectiveness of the two oral medications, with the hope that it can reduce or stop the progress of the autoimmune process and preserve the cells that produce insulin, essentially stopping the development of type 1 diabetes.
In type 1 diabetes the body does not produce insulin, which the body needs to obtain glucose from the bloodstream to the cells.
Scientific reports have suggested that high doses of Omega 3 and vitamin D supplements can improve autoimmune conditions such as type 1 diabetes.
"What has been found is that Omega 3 and vitamin D, on a certain dose, become anti -inflammatories and immunomodulators," which means that they can change and regulate the body's immune system, says Dr. Camillo Ricordi, Director of the Diabetes Research Institute of the University of Miami.
Inflammation can be a trigger for autoimmunity that begins the disease.It can also affect insulin resistance, says Ricordi in a statement announcing the study.
The results of a study of a recent case that examined the role of Omega 3 and vitamin D in the preservation of the beta function of cells (to store and release insulin) in three pediatric patients with type 1 diabetes, justified more researchFrom the therapeutic strategy, he says.
“The combination of the two is safe and very cheap compared to other expensive biological drugs that are being tested, so I think it is a safe and economical alternative that can have a deep impact not only on type 1 diabetes but also in othersAutoimmune conditions in general, ”says Ricordi.
The Diabetes Research Institute is enrolling 56 adults and children between the ages of six to 65 years with type 1 diabetes, both with new and diagnosed diagnosis for more than six months.Study participants will take vitamin D alone or in combination with Omega 3 for a year, followed by an observation period of one year.
"We are in the beginning ... and I am very excited to be able to try this hypothesis," says Ricardi.
But he is being careful to advertise the therapy before being proven.
"One of our problems is that once it is explained, the test is so simple that people treat it on their own," he says.In fact, there are tests that can be ensured online to control Omega 3 and vitamin D levels with a simple puncture on the finger and sending a blood sample.
“But it must be done under medical supervision.I cannot recommend that someone treats something that is not yet proven ”,Ricordi adds."I recommend registering in the test and obtaining validation of the hypothesis or discussing it with your doctor."
It is also important to use a highly purified form of Omega 3.
"You should not get a low quality product that may have contaminants such as Mercury, especially if you are consuming it in higher doses," he says.
Studying the effects of Omega 3 and Vitamin D can change health care as we know it, says Ricordi.
"There are evidence that is studying the effects of the combination of Omega 3 and Vitamin D to prevent cardiovascular diseases, strokes and cancer," he says."You will see more clinical tests on this topic in the future."